7.50
price down icon0.13%   -0.010
after-market Dopo l'orario di chiusura: 7.50
loading

Avita Medical Inc Borsa (RCEL) Ultime notizie

pulisher
08:01 AM

6 Analysts Assess AVITA Medical: What You Need To Know - Benzinga

08:01 AM
pulisher
Apr 03, 2025

AVITA Medical Inc Announces U.S. Commercial Launch Of Cohealyx - MarketScreener

Apr 03, 2025
pulisher
Apr 03, 2025

Avita Medical's Cohealyx Wound Treatment Makes Commercial Launch in US; Shares Down 4% - MarketScreener

Apr 03, 2025
pulisher
Apr 03, 2025

AVITA Medical Launches Wound Care Product Cohealyx in US - MarketScreener

Apr 03, 2025
pulisher
Apr 03, 2025

AVITA Medical Launches Cohealyx, Supporting Healing and Unlocking New Market Opportunity - The Manila Times

Apr 03, 2025
pulisher
Apr 03, 2025

AVITA Medical launches Cohealyx in the U.S. market - Investing.com

Apr 03, 2025
pulisher
Apr 03, 2025

Game-Changing Wound Care: AVITA's New Cohealyx Shows Superior Healing Results - Stock Titan

Apr 03, 2025
pulisher
Apr 03, 2025

AVITA Medical, Inc. (NASDAQ:RCEL) Sees Large Growth in Short Interest - MarketBeat

Apr 03, 2025
pulisher
Apr 02, 2025

Long Term Trading Analysis for (RCEL) - news.stocktradersdaily.com

Apr 02, 2025
pulisher
Apr 01, 2025

Does Avita Medical (RCEL) Have the Potential to Rally 73.72% as Wall Street Analysts Expect? - MSN

Apr 01, 2025
pulisher
Mar 22, 2025

AVITA Medical (NASDAQ:RCEL) Earns "Buy" Rating from D. Boral Capital - MarketBeat

Mar 22, 2025
pulisher
Mar 20, 2025

Investors overly negative on undervalued ASX share - Morningstar.com.au

Mar 20, 2025
pulisher
Mar 20, 2025

Global healthcare stocks for your watchlist - Morningstar Australia

Mar 20, 2025
pulisher
Mar 19, 2025

AVITA Medical’s SWOT analysis: regenerative medicine stock faces growth hurdles - Investing.com

Mar 19, 2025
pulisher
Mar 19, 2025

AVITA Medical signs manufacturing deal with Stedical Scientific for PermeaDerm - MSN

Mar 19, 2025
pulisher
Mar 19, 2025

AVITA Medical (NASDAQ:RCEL) Receives “Buy” Rating from D. Boral Capital - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

What Analysts Are Saying About AVITA Medical Stock - Benzinga

Mar 18, 2025
pulisher
Mar 18, 2025

AVITA Medical Announces Exclusive Manufacturing and Distribution Agreements with Stedical Scientific - The Manila Times

Mar 18, 2025
pulisher
Mar 17, 2025

AVITA Secures Manufacturing, Amends Distribution Agreement with US-Based Healthcare Tech Provider; Shares Rise 7% - Marketscreener.com

Mar 17, 2025
pulisher
Mar 17, 2025

AVITA Medical (ASX:AVH) Announces New Manufacturing and Distribution Agreements - The Capital Club

Mar 17, 2025
pulisher
Mar 17, 2025

Avita Medical Boosts Production with New Agreement - TipRanks

Mar 17, 2025
pulisher
Mar 17, 2025

AVITA Medical Boosts Revenue Share to 60% in Strategic PermeaDerm Deal - Stock Titan

Mar 17, 2025
pulisher
Mar 12, 2025

(RCEL) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com

Mar 12, 2025
pulisher
Mar 12, 2025

Skin Burns Treatment Market 2034: Clinical Trials, EMA, PDMA, FDA Approvals, Drugs Market, Prevalence, Medication, Statistics, Therapies, Companies by DelveInsight - The Globe and Mail

Mar 12, 2025
pulisher
Mar 06, 2025

Investors Don't See Light At End Of AVITA Medical, Inc.'s (NASDAQ:RCEL) Tunnel - Simply Wall St

Mar 06, 2025
pulisher
Mar 01, 2025

How To Trade (RCEL) - Stock Traders Daily

Mar 01, 2025
pulisher
Feb 27, 2025

Avita Medical LimitedADR to Host Earnings Call - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 27, 2025

AVITA Medical to Present at TD Cowen's 45ᵗʰ Annual Health Care Conference - The Manila Times

Feb 27, 2025
pulisher
Feb 26, 2025

Can AVITA Medical's Conference Appearance Signal New Growth Opportunities in Wound Care? - StockTitan

Feb 26, 2025
pulisher
Feb 26, 2025

Burns Pipeline 2024: Therapies, MOA Insights, and Key Clinical - openPR

Feb 26, 2025
pulisher
Feb 24, 2025

D. Boral Capital Lowers AVITA Medical (NASDAQ:RCEL) Price Target to $22.00 - MarketBeat

Feb 24, 2025
pulisher
Feb 23, 2025

AVITA Medical (RCEL) to Release Quarterly Earnings on Thursday - MarketBeat

Feb 23, 2025
pulisher
Feb 22, 2025

Insider Buying: Robert Mcnamara Acquires 10,000 Shares of AVITA Medical Inc (RCEL) - GuruFocus.com

Feb 22, 2025
pulisher
Feb 21, 2025

Insider Buying: AVITA Medical, Inc. (NASDAQ:RCEL) Director Acquires 10,000 Shares of Stock - MarketBeat

Feb 21, 2025
pulisher
Feb 21, 2025

Wall Street Analysts Predict a 52.64% Upside in Avita Medical (RCEL): Here's What You Should Know - MSN

Feb 21, 2025
pulisher
Feb 21, 2025

Avita medical CFO David O'Toole acquires $9,900 in common stock - Investing.com Australia

Feb 21, 2025
pulisher
Feb 21, 2025

Avita Medical director Robert McNamara purchases $100,900 in stock By Investing.com - Investing.com South Africa

Feb 21, 2025
pulisher
Feb 21, 2025

Avita medical CFO David O’Toole acquires $9,900 in common stock - Investing.com India

Feb 21, 2025
pulisher
Feb 20, 2025

AVITA Medical, Inc. (NASDAQ:RCEL) CFO Purchases $10,250.00 in Stock - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Avita Medical director Robert McNamara purchases $100,900 in stock - Investing.com India

Feb 20, 2025
pulisher
Feb 20, 2025

Avita medical CFO David O'Toole acquires $9,900 in common stock By Investing.com - Investing.com South Africa

Feb 20, 2025
pulisher
Feb 20, 2025

AVITA Medical, Inc. (RCEL): A Bull Case Theory - Insider Monkey

Feb 20, 2025
pulisher
Feb 19, 2025

When (RCEL) Moves Investors should Listen - Stock Traders Daily

Feb 19, 2025
pulisher
Feb 19, 2025

D. Boral Capital Reiterates Buy Rating for AVITA Medical (NASDAQ:RCEL) - MarketBeat

Feb 19, 2025
pulisher
Feb 18, 2025

After Sales Rebound In January, AVITA Is Set Up For A Monster Year - Seeking Alpha

Feb 18, 2025
medical_devices STE
$212.61
price down icon 3.97%
medical_devices PHG
$22.08
price down icon 7.46%
medical_devices ZBH
$107.34
price down icon 4.72%
$59.83
price down icon 3.19%
$60.51
price down icon 15.96%
medical_devices EW
$69.36
price down icon 4.96%
Capitalizzazione:     |  Volume (24 ore):